Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Current Assets (2017 - 2024)

Solid Biosciences' Current Assets history spans 8 years, with the latest figure at $179.5 million for Q3 2024.

  • For Q3 2024, Current Assets rose 21.0% year-over-year to $179.5 million; the TTM value through Sep 2024 reached $179.5 million, up 21.0%, while the annual FY2023 figure was $129.7 million, 40.93% down from the prior year.
  • Current Assets for Q3 2024 was $179.5 million at Solid Biosciences, down from $197.6 million in the prior quarter.
  • Across five years, Current Assets topped out at $274.3 million in Q1 2021 and bottomed at $27.2 million in Q3 2020.
  • The 5-year median for Current Assets is $179.5 million (2024), against an average of $170.6 million.
  • The largest annual shift saw Current Assets tumbled 76.07% in 2020 before it surged 779.21% in 2021.
  • A 5-year view of Current Assets shows it stood at $158.9 million in 2020, then skyrocketed by 40.09% to $222.6 million in 2021, then dropped by 1.34% to $219.6 million in 2022, then crashed by 40.93% to $129.7 million in 2023, then soared by 38.36% to $179.5 million in 2024.
  • Per Business Quant, the three most recent readings for SLDB's Current Assets are $179.5 million (Q3 2024), $197.6 million (Q2 2024), and $214.2 million (Q1 2024).